Product logins

Find logins to all Clarivate products below.


Trauma Devices and Large-Joint Reconstructive Implants | Medtech 360 | Market Analysis | Asia Pacific (Supplemental) | 2016

The Asia Pacific market for trauma devices and large-joint reconstructive joint implants will remain highly lucrative over the forecast period, despite slightly slower economic growth in China. The market will be supported by demographic factors as well as improved access to trauma care, although ongoing cost constraints will limit adoption of newer premium-priced devices, somewhat hindering revenues.

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the trauma devices and reconstructive joint implant in the Asia Pacific countries, including country-level data for 13 major countries and aggregate data for the rest of Asia Pacific across a 10-year period.

Related Medtech Insights Reports

Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Trauma Devices – Market Insights – Latin America
The Latin American trauma device market is positioned for strong growth, driven by the rapid expansion of highvolume product segments, a growing aging population, and increasingly favorable…
Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…